Zhongke Meiling Cryogenics Co (BJSE:920992) Stock Based Compensation: ¥0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920992 Zhongke Meiling Cryogenics Co Ltd BJSE:920992
62 GF Score
Price ¥12.08
GF Value ¥14.07
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Zhongke Meiling Cryogenics Co Stock Based Compensation?

Zhongke Meiling Cryogenics Co BJSE:920992 62 Stock Based Compensation is ¥0.0 Mil as of Jun. 2026. GuruFocus rates BJSE:920992 with a GF Score™ of 62/100 and a GF Value™ of ¥14.07 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Zhongke Meiling Cryogenics Co's Stock Based Compensation for the three months ended in Jun. 2026 was ¥0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 was ¥0.0 Mil.

Zhongke Meiling Cryogenics Co Stock Based Compensation Related Terms

Zhongke Meiling Cryogenics Co Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Zhongke Meiling Cryogenics Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhongke Meiling Cryogenics Co Stock Based Compensation Chart

Zhongke Meiling Cryogenics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Zhongke Meiling Cryogenics Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BJSE:920992
62GF Score
Zhongke Meiling Cryogenics Co Ltd BJSE:920992
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhongke Meiling Cryogenics Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

What does a Stock Based Compensation of ¥0.0 Mil mean?
Zhongke Meiling Cryogenics Co (BJSE:920992) has a Stock Based Compensation of ¥0.0 Mil as of Jun. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Zhongke Meiling Cryogenics Co and its competitors.
Is Zhongke Meiling Cryogenics Co's Stock Based Compensation too high?
Zhongke Meiling Cryogenics Co's current Stock Based Compensation is ¥0.0 Mil. Overall, Zhongke Meiling Cryogenics Co has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhongke Meiling Cryogenics Co's Stock Based Compensation compare to ABT and SYK?
Zhongke Meiling Cryogenics Co's Stock Based Compensation of ¥0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Zhongke Meiling Cryogenics Co and its competitors. Zhongke Meiling Cryogenics Co's current Stock Based Compensation is ¥0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongke Meiling Cryogenics Co stock overvalued right now?
Based on GuruFocus' analysis, Zhongke Meiling Cryogenics Co (BJSE:920992) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.07, compared to a current price of ¥12.08 — trading 14.1% below its estimated fair value. The current Stock Based Compensation is ¥0.0 Mil. Zhongke Meiling Cryogenics Co's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Zhongke Meiling Cryogenics Co (BJSE:920992), the current Stock Based Compensation is ¥0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhongke Meiling Cryogenics Co (BJSE:920992) Overvalued in 2026?

Based on GuruFocus' analysis, Zhongke Meiling Cryogenics Co stock appears to be undervalued. The current stock price of ¥12.08 is trading 14.1% below its estimated GF Value™ of ¥14.07. GuruFocus considers Zhongke Meiling Cryogenics Co to be Modestly Undervalued.

Key valuation signals for BJSE:920992:

  • Stock Based Compensation: ¥0.0 Mil
  • GF Value™: ¥14.07 vs. price of ¥12.08 (14.1% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the BJSE:920992 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhongke Meiling Cryogenics Co Business Description

Address No. 1862 Zishi Road, Economic and Technological Development Zone, Anhui Province, Hefei City, CHN, 230601
Zhongke Meiling Cryogenics Co Ltd engages in research and development, production, and sales of biomedical cryogenic storage equipment. The company's main products include a lab / medical refrigerator and freezer, ultra-low temperature freezer, blood bank refrigerator, inventory rack/box, professional cold room, and bio-bank management.
62GF Score

Get the complete analysis for BJSE:920992

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.08
Price
¥14.07
GF Value